AbCellera Biologics Inc. ABCL Gain on contingent consideration
Gain on contingent consideration at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept abcl:EffectiveIncomeTaxRateReconciliationGainOnContingentConsideration.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s gain on contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s gain on contingent consideration?
- AbCellera Biologics Inc. (ABCL) reported gain on contingent consideration of -$3.19M in Q4 2024.
- What does gain on contingent consideration mean?
- This reflects the tax treatment of gains or losses arising from changes in the fair value of contingent consideration liabilities, such as earn-outs from acquisitions. It isolates the impact of non-operating financial adjustments on the tax provision. Investors track this to distinguish between core operational tax efficiency and gains driven by accounting revaluations.